Introduction
Rare Bleeding Disorders [RBDs] account for 3-5% of all inherited coagulation disorders and are usually transmitted as autosomal recessive traits. In some countries the prevalence is higher due to consanguineous marriage.
The Rare Bleeding Disorders [RBDs] include:
- Fibrinogen deficiency
- Factor II [Prothrombin deficiency]
- Factor V deficiency
- Factor VII deficiency
- Factor V and VIII deficiency
- Factor XI deficiency
- Factor XIII deficiency
The bleeding manifestations that individuals with a rare bleeding disorder exhibit, vary significantly both between disorders and in patients with the same disorder. Bleeding symptoms including gum bleeding, expistaxes, menorrhagia and bleeding from minor wounds, are also frequently reported in healthy individuals
A Lifelong Clinical Bleeding Scoring System for the Rare Bleeding Disorders [EN-RBD-BSS] was developed both to identify individuals with a rare bleeding disorder but in addition to separate individuals with a bleeding disorder from those without one.
The algorithm was developed from data derived from 492 patients with a Rare Bleeding Disorder [RBD] enrolled in the European Network of Rare Bleeding Disorders [EN-RBD]. For more information on how the algorithm was developed - see References.
1Diffuse bleeding that lasts at least 10 minutes and/or requires medical attention in the case of epistaxis or oral cavity bleeding; a haematoma >3cm that is considered disproportionate to the causative trauma, when it is not possible to establish a localised lesion and define the haemorrhage volume in the case of CNS bleeding.
1Diffuse bleeding that lasts at least 10 minutes and/or requires medical attention in the case of epistaxis or oral cavity bleeding; a haematoma >3cm that is considered disproportionate to the causative trauma, when it is not possible to establish a localised lesion and define the haemorrhage volume in the case of CNS bleeding.
2Oral cavity bleeding includes gum bleeding, tooth eruption, spontaneous tooth loss bleeding, bleeding occurring after bites/wounds to the lips, cheek and tongue.
Gum bleeding due to a toothbrush should be evaluated as normal; gum bleeding should be considered significant when it causes bloody sputum.
1Diffuse bleeding that lasts at least 10 minutes and/or requires medical attention in the case of epistaxis or oral cavity bleeding; a haematoma >3cm that is considered disproportionate to the causative trauma, when it is not possible to establish a localised lesion and define the haemorrhage volume in the case of CNS bleeding.
3Disabling means that hemarthrosis has led to compromised motility.
4Any gastrointestinal bleeding that is not explained by the presence of a specific disease hould be considered as spontaneous. Bleeding associated with an ulcer, portal hypertension,hemorrhoids or angiodysplasia should be considered as not spontaneous.
Melena and hematemesis, if not associated with the conditions listed above, should be considered as possible signs of a bleeding disorder.
1Diffuse bleeding that lasts at least 10 minutes and/or requires medical attention in the case of epistaxis or oral cavity bleeding; a haematoma >3cm that is considered disproportionate to the causative trauma, when it is not possible to establish a localised lesion and define the haemorrhage volume in the case of CNS bleeding.
5Postpartum bleeding/haemorrhage should be considered as spontaneous when it is not associated with an identified gynaecological or obstetrical cause for primary postpartum haemorrhage [PPH].
6See References for the definition of Major and Minor surgery.
7With or without adenoidectomy
6See References for the definition of Major and Minor surgery.
| Total Score [Total_Score] | |||
| Bleeding Score | |||
| RBD Probability [%] |
|||
The algorithm was able to differentiate patients with a RBD from healthy individuals. A bleeding score value of 1.5 had the highest sensitivity (67.1%) and specificity (73.8%) in discriminating patients with a RBD from those without.
For additional information on the analysis of data - see References.
Click HERE to return to the top of the page.
